Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionserine-type endopeptidase activity

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

5.32e-06190476GO:0004252
GeneOntologyMolecularFunctionserine-type peptidase activity

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

8.70e-06207476GO:0008236
GeneOntologyMolecularFunctionserine hydrolase activity

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

9.97e-06212476GO:0017171
GeneOntologyMolecularFunctionendopeptidase activity

BLMH PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

6.11e-05430477GO:0004175
GeneOntologyMolecularFunctionpeptidase activity

BLMH PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 USP25 TMPRSS11A

1.29e-04654478GO:0008233
DomainTRYPSIN_SER

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

2.58e-07106476PS00135
DomainTRYPSIN_HIS

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

2.72e-07107476PS00134
DomainPeptidase_S1A

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

3.76e-07113476IPR001314
DomainTRYPSIN_DOM

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

4.18e-07115476PS50240
DomainTryp_SPc

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

4.62e-07117476SM00020
DomainTrypsin

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

5.64e-07121476PF00089
DomainTrypsin_dom

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

5.64e-07121476IPR001254
DomainPeptidase_S1_PA

PRSS1 TMPRSS9 PAMR1 GZMB PRSS55 TMPRSS11A

6.21e-07123476IPR009003
DomainTRYPSIN_SER

PRSS1 TMPRSS9 GZMB PRSS55 TMPRSS11A

3.04e-0690475IPR033116
DomainTRYPSIN_HIS

PRSS1 TMPRSS9 GZMB PRSS55 TMPRSS11A

5.90e-06103475IPR018114
DomainE2F_CC-MB

E2F4 E2F5

9.24e-056472IPR032198
DomainE2F_CC-MB

E2F4 E2F5

9.24e-056472PF16421
DomainE2F

E2F4 E2F5

1.72e-048472IPR015633
DomainE2F_TDP

E2F4 E2F5

3.36e-0411472PF02319
DomainE2F_TDP

E2F4 E2F5

3.36e-0411472SM01372
DomainE2F_WHTH_DNA-bd_dom

E2F4 E2F5

3.36e-0411472IPR003316
DomainSEA

MUC3B TMPRSS11A

1.39e-0322472PF01390
DomainSEA

MUC3B TMPRSS11A

1.52e-0323472PS50024
DomainSEA_dom

MUC3B TMPRSS11A

1.52e-0323472IPR000082
Domain-

LAMA2 CLSTN2 ADGRG4

1.76e-03954732.60.120.200
DomainConA-like_dom

LAMA2 TRIM49D1 CLSTN2 ADGRG4

2.21e-03219474IPR013320
DomainEGF

MUC3B PAMR1 LAMA2 TEK

2.85e-03235474SM00181
DomainEGF-like_dom

MUC3B PAMR1 LAMA2 TEK

3.51e-03249474IPR000742
DomainEGF_1

MUC3B PAMR1 LAMA2 TEK

3.82e-03255474PS00022
DomainEGF-like_CS

MUC3B PAMR1 LAMA2 TEK

4.15e-03261474IPR013032
DomainEGF_2

MUC3B PAMR1 LAMA2 TEK

4.38e-03265474PS01186
DomainWD40_repeat_dom

SEH1L AAMP DNAI4 SPAG9

6.53e-03297474IPR017986
DomainCUB

KREMEN1 PAMR1

6.76e-0349472PF00431
DomainCUB

KREMEN1 PAMR1

7.03e-0350472SM00042
Domain-

KREMEN1 PAMR1

7.59e-03524722.60.120.290
DomainCUB

KREMEN1 PAMR1

7.87e-0353472PS01180
DomainCUB_dom

KREMEN1 PAMR1

9.06e-0357472IPR000859
Domain-

SEH1L AAMP DNAI4 SPAG9

9.69e-033334742.130.10.10
DomainWD40/YVTN_repeat-like_dom

SEH1L AAMP DNAI4 SPAG9

9.89e-03335474IPR015943
DomainTSP_1

ADAMTSL1 CFP

1.10e-0263472PF00090
DomainUBA-like

USP25 TNRC6C

1.13e-0264472IPR009060
DomainTSP1

ADAMTSL1 CFP

1.17e-0265472SM00209
DomainTSP1_rpt

ADAMTSL1 CFP

1.17e-0265472IPR000884
DomainTSP1

ADAMTSL1 CFP

1.17e-0265472PS50092
Pubmed

Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.

KMT2B E2F4 E2F5

2.19e-07949316951254
Pubmed

Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system.

LAMA2 GRIN1 TBR1

9.46e-071449319240213
Pubmed

E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control.

E2F4 E2F5

1.94e-06249211030352
Pubmed

Putative complement control protein CSMD3 dysfunction impairs synaptogenesis and induces neurodevelopmental disorders.

LAMA2 GRIN1 TBR1

3.97e-062249335245678
Pubmed

E2f4 and E2f5 are essential for the development of the male reproductive system.

E2F4 E2F5

5.83e-06349226825228
Pubmed

Transcriptional induction of NF-κB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells.

E2F4 E2F5

5.83e-06349237567906
Pubmed

Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.

E2F4 E2F5

5.83e-06349215855772
Pubmed

Interplay between the retinoblastoma related pRb2/p130 and E2F-4 and -5 in relation to JCV-TAg.

E2F4 E2F5

5.83e-06349217385710
Pubmed

The subcellular localization of E2F-4 is cell-cycle dependent.

E2F4 E2F5

1.16e-0544929144196
Pubmed

Identification of Tbr-1/CASK complex target genes in neurons.

GRIN1 TBR1

1.16e-05449215584924
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ADAMTSL1 ZNF451 SPAG9 GREB1

1.50e-051054949628581
Pubmed

Identification of proteins that interact with alpha A-crystallin using a human proteome microarray.

SEH1L LIMA1 OTOGL SULF1

2.37e-0511849424453475
Pubmed

E2F: a nodal point in cell cycle regulation.

E2F4 E2F5

2.91e-0564929426200
Pubmed

Expression of the E2F family of transcription factors during murine development.

E2F4 E2F5

2.91e-05649210853823
Pubmed

The regulation of E2F by pRB-family proteins.

E2F4 E2F5

2.91e-0564929694791
Pubmed

Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.

E2F4 E2F5

4.07e-05749212860972
Pubmed

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

E2F4 E2F5

4.07e-0574927958925
Pubmed

E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression.

E2F4 E2F5

4.07e-05749212150994
Pubmed

pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.

E2F4 E2F5

4.07e-05749212789259
Pubmed

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.

E2F4 E2F5

4.07e-0574927892279
Pubmed

Expression patterns of the E2F family of transcription factors during mouse nervous system development.

E2F4 E2F5

4.07e-0574929376316
Pubmed

ASCOM controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity.

KMT2B GRIN1

4.07e-05749219556342
Pubmed

Aberrant regulation of survivin by the RB/E2F family of proteins.

E2F4 E2F5

4.07e-05749215271987
Pubmed

Expression patterns of the E2F family of transcription factors during murine epithelial development.

E2F4 E2F5

5.42e-0584929149906
Pubmed

E2F-4, a new member of the E2F transcription factor family, interacts with p107.

E2F4 E2F5

5.42e-0584927958924
Pubmed

The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification.

E2F4 E2F5

5.42e-05849215448153
Pubmed

Canonical and atypical E2Fs regulate the mammalian endocycle.

E2F4 E2F5

5.42e-05849223064266
Pubmed

EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2.

E2F4 E2F5

5.42e-05849219457859
Pubmed

Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.

E2F4 E2F5

5.42e-05849216360038
Pubmed

Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F.

E2F4 E2F5

5.42e-05849217062573
Pubmed

Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex.

E2F4 E2F5

8.69e-051049220392944
Pubmed

Rb is critical in a mammalian tissue stem cell population.

E2F4 E2F5

8.69e-051049217210791
Pubmed

Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors.

E2F4 E2F5

1.06e-041149215735762
Pubmed

Regulation of radial glial survival by signals from the meninges.

LAMA2 TBR1

1.06e-041149219535581
Pubmed

USP25 contributes to defective neurogenesis and cognitive impairments.

USP25 TBR1

1.06e-041149237171286
Pubmed

Target gene specificity of E2F and pocket protein family members in living cells.

E2F4 E2F5

1.27e-041249210913163
Pubmed

Af9/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex.

GRIN1 TBR1

1.27e-041249220348416
Pubmed

Fukutin-related protein alters the deposition of laminin in the eye and brain.

LAMA2 TBR1

1.50e-041349221900571
Pubmed

Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies.

CLSTN2 GRIN1

1.50e-041349233374598
Pubmed

Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.

E2F4 E2F5

1.75e-041449217531812
Pubmed

Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.

E2F4 E2F5

1.75e-04144929190208
Pubmed

The Rb-related p130 protein controls telomere lengthening through an interaction with a Rad50-interacting protein, RINT-1.

E2F4 E2F5

1.75e-041449216600870
Pubmed

Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.

E2F4 E2F5

2.02e-041549217255939
Pubmed

Pattern of expression of p53, its family members, and regulators during early ocular development and in the post-mitotic retina.

E2F4 E2F5

2.30e-041649222714890
Pubmed

Lhx2 regulates a cortex-specific mechanism for barrel formation.

GRIN1 TBR1

2.61e-041749224262147
Pubmed

Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo.

GRIN1 TBR1

2.93e-041849218599437
Pubmed

Endothelial Arid1a deletion disrupts the balance among angiogenesis, neurogenesis and gliogenesis in the developing brain.

TBR1 TEK

3.27e-041949236916004
Pubmed

TRIM67 Implicates in Regulating the Homeostasis and Synaptic Development of Mitral Cells in the Olfactory Bulb.

GRIN1 TBR1

3.27e-041949237686246
Pubmed

Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.

TGM1 GZMB

3.27e-041949212721789
Pubmed

Rap1 GTPases Are Master Regulators of Neural Cell Polarity in the Developing Neocortex.

LAMA2 TBR1

4.41e-042249226733533
Pubmed

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

QSOX1 LAMA2 CFP CD163

4.75e-0425749416335952
Pubmed

Endothelial cells regulated by RNF20 orchestrate the proliferation and differentiation of neural precursor cells during embryonic development.

TBR1 TEK

4.83e-042349236103829
Pubmed

The E2F6 repressor activates gene expression in myocardium resulting in dilated cardiomyopathy.

E2F4 E2F5

4.83e-042349222403008
Pubmed

Novel interactors and a role for supervillin in early cytokinesis.

LIMA1 STARD9

7.18e-042849220309963
Pubmed

The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein.

ZNF263 C16orf96

7.71e-042949212438443
Pubmed

Effects of Pparγ1 deletion on late-stage murine embryogenesis and cells that undergo endocycle.

E2F4 E2F5

7.71e-042949234246625
Pubmed

Large-scale identification of genes implicated in kidney glomerulus development and function.

RHPN1 LAMA2

1.06e-033449216498405
Pubmed

Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.

E2F4 E2F5

1.39e-033949219738611
GeneFamilyProteases, serine

PRSS1 TMPRSS9 PRSS55 TMPRSS11A

6.46e-0663354738
GeneFamilyE2F transcription factors

E2F4 E2F5

1.01e-048352982
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADAMTSL1 PAMR1 SULF1 LAMA2 CLSTN2 GREB1 ADGRG4

1.95e-0920048774e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor

ADAMTSL1 PAMR1 SULF1 LAMA2 GREB1 ADGRG4

5.90e-08192486d21f0f577156f17c899b08871046a26b88aea011
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTSL1 SULF1 LAMA2 CLSTN2 GREB1 ADGRG4

6.47e-08195486f54bc4454270ff06e85596f98199372b50d0179f
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADAMTSL1 NHSL2 SULF1 STARD9 LAMA2 CLSTN2

7.52e-082004860c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor

ADAMTSL1 SULF1 LAMA2 CLSTN2 GREB1

1.61e-061844852b7e6f91e11c228f0521e099886867d9e998e78d
ToppCellfacs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LIMA1 PAMR1 SULF1 TEK TMPRSS11A

1.79e-06188485aa516273cdde53c8c0295f06830972388f890c97
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2 ADGRG4

1.79e-06188485ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADAMTSL1 LAMA2 CLSTN2 GREB1 ADGRG4

1.83e-06189485d531399749409d614adca13d181830c6e3287508
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor

ADAMTSL1 SULF1 LAMA2 GREB1 ADGRG4

1.88e-061904857dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2 ADGRG4

1.88e-06190485efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

ADAMTSL1 PAMR1 SULF1 LAMA2 CLSTN2

1.98e-06192485e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ADAMTSL1 PAMR1 SULF1 LAMA2 CLSTN2

2.03e-061934859ab47b360bee1d4f1092c2269e58acebe9584021
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ADAMTSL1 PAMR1 SULF1 LAMA2 CLSTN2

2.14e-06195485ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2 CLSTN2

2.14e-06195485803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2 CLSTN2

2.14e-061954854f70157d42a16ff0259bc24a62803c4df4285c44
ToppCellCOPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class

ADAMTSL1 PAMR1 SULF1 LAMA2 GREB1

2.19e-061964854930eeb303d174c28fd91021723e26fdf1af9170
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PAMR1 STARD9 LAMA2 TNS3 CA4

2.25e-061974852872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ADAMTSL1 PAMR1 SULF1 LAMA2 GREB1

2.36e-06199485f835e7ffe976843b0edbf695762d463da85793f3
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ADAMTSL1 PAMR1 SULF1 LAMA2 GREB1

2.36e-06199485993fa050a095017135a6e723c77cd38b9d782e58
ToppCellBiopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

ADAMTSL1 PAMR1 SULF1 LAMA2 ADGRG4

2.42e-062004858d75ce89393df452defacf2ec9a5bd4b7708afbb
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADAMTSL1 SULF1 LAMA2 CLSTN2 GREB1

2.42e-06200485ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ZNF263 MYOM1 STARD9 CFP

2.01e-05149484a85a051e0d82430160967e72fa04b55f43e84513
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZNF263 MYOM1 STARD9 CFP

2.06e-051504847a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

QSOX1 LIMA1 E2F5 TEK

3.21e-051684843bddf411a60137a8883fc9e77586e4719b0d6067
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

QSOX1 LIMA1 E2F5 TEK

3.21e-05168484b6d948857ee652351ddbe383b75fdd1721cd8721
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NHSL2 OTOGL CLSTN2 TBR1

3.36e-0517048487cac555f16b6c2ef3d1b3a00f992d8bf2237b50
ToppCellnormal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

BLMH DNAI4 E2F5 FAN1

3.36e-05170484c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCellTCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9

MYOM1 PAMR1 STARD9 CA4

3.68e-051744847f8f5fafae08676d2b90cab9802c3c9320f1370e
ToppCellTCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9

MYOM1 PAMR1 STARD9 CA4

3.68e-05174484e2f240d60bffbe8e6d60f0bb405b231bd3c96875
ToppCellTCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9

MYOM1 PAMR1 STARD9 CA4

3.68e-051744840f3ec0d0d4344e10c9b48adc9174123f6402dc51
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTSL1 SULF1 CLSTN2 TBR1

3.68e-05174484e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCellTCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9

MYOM1 PAMR1 STARD9 CA4

3.68e-051744841aadbf2642b6d1320ceabd92e6ff59e11f16c315
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTSL1 SULF1 CLSTN2 TBR1

3.94e-05177484bde307e67ad8e48a5ff4c0827015f4688f6b3e46
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTSL1 SULF1 CLSTN2 TBR1

4.11e-051794847954c0026754ab869b88ab7feb13c2f27d6e272d
ToppCellfacs-Thymus-Epithelium-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LIMA1 PAMR1 TEK CA4

4.29e-05181484bce56e12ab93693c9c04fa6aad8f2e1dff0c4d45
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 SULF1 LAMA2 CLSTN2

4.39e-0518248444764676ed3f51ba171ce63f669390392fa50a43
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 SULF1 LAMA2 CLSTN2

4.39e-05182484d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

LAMA2 CLSTN2 GREB1 TEK

4.58e-0518448467164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 ADGRG4

4.58e-05184484e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCelldroplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 SULF1 LAMA2 C16orf96

4.58e-051844843bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 PAMR1 LAMA2 TEK

4.67e-051854843cd0686a14e734a0f243070ab939adcb4c454478
ToppCelldroplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 SULF1 LAMA2 C16orf96

4.67e-0518548433cc0e9d8b54cb7408b51235f2a70e044ebae04d
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 PAMR1 LAMA2 TEK

4.67e-0518548400258f458cbf6d36449db95528a6b5038d731d2d
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 PAMR1 LAMA2 TEK

4.67e-05185484a94694e226856bc5b168464f52d76004145717a5
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor

ADAMTSL1 PAMR1 LAMA2 GREB1

4.67e-05185484fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCellCOVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations)

ADAMTSL1 PAMR1 LAMA2 GREB1

4.67e-05185484a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCelldroplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 SULF1 LAMA2 C16orf96

4.67e-051854849954fc85b183c1cc45c3c24e3dadc7984ee6f649
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

KREMEN1 NHSL2 CFP CD163

4.87e-051874843b1439018e265a61d9599e307a202e3c2f60ed32
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

KREMEN1 NHSL2 CFP CD163

4.87e-05187484e99bc27d212c74da37770297122a4b30445ccd0d
ToppCellP15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

QSOX1 NHSL2 SULF1 TEK

4.98e-0518848450b27fc12347ca16bd62333baf345c83cb422a8f
ToppCellControl-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations)

ADAMTSL1 SULF1 LAMA2 GREB1

4.98e-05188484706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 CLSTN2

5.18e-051904842306aa9dbeaef3be8484a5b236605de23cd75d4c
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 CLSTN2

5.18e-051904841f83f7f24288a3b9ab33c2e113e845dba96adc8a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 CLSTN2

5.29e-05191484a58c75e9580139fb370b498d95660f10f3a2a27b
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PAMR1 SULF1 LAMA2 ADGRG4

5.29e-051914842c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCellRV-01._Fibroblast_I|World / Chamber and Cluster_Paper

PAMR1 STARD9 LAMA2 CLSTN2

5.29e-0519148470c067c54084bfb02c29bab085f4defd477194fb
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 CLSTN2

5.40e-051924849093a9e94a25682d109a7f6edc256a25a61103a0
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LIMA1 PAMR1 SULF1 LAMA2

5.40e-051924848d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCellfacs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 PAMR1 SULF1 LAMA2

5.40e-05192484a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 CLSTN2

5.40e-051924849ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCellfacs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL1 PAMR1 SULF1 LAMA2

5.40e-05192484eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCellMesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor

ADAMTSL1 PAMR1 SULF1 LAMA2

5.40e-05192484a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

PAMR1 SULF1 LAMA2 CLSTN2

5.51e-05193484dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

PAMR1 SULF1 LAMA2 CLSTN2

5.51e-05193484261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PAMR1 SULF1 LAMA2 TEK

5.62e-051944847b6ec45adb7ece3c8a7b78c5782413b5825effe2
ToppCelldroplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULF1 LAMA2 TEK CA4

5.62e-05194484775600880bb77781de48085d8744c1030223de1f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PAMR1 NHSL2 SULF1 LAMA2

5.62e-05194484c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCellLV-02._Fibroblast_II|LV / Chamber and Cluster_Paper

PAMR1 SULF1 LAMA2 CLSTN2

5.62e-05194484014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCelldroplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SULF1 LAMA2 TEK CA4

5.62e-0519448404ecb609d233a4b12e275c604810937830363e17
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2

5.62e-0519448490efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2

5.62e-05194484df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ADAMTSL1 OTOGL SULF1 CA4

5.73e-05195484d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ADAMTSL1 OTOGL SULF1 CA4

5.73e-0519548419853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

PAMR1 SULF1 LAMA2 CLSTN2

5.73e-05195484a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PAMR1 NHSL2 SULF1 LAMA2

5.73e-051954843c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LIMA1 PAMR1 SULF1 LAMA2

5.85e-05196484525d6c8a277364e624e7cc586275f8a891436b57
ToppCellIPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class

ADAMTSL1 SULF1 LAMA2 GREB1

5.85e-05196484f7ae604ba32b322d86d68b2b54892e7c6ab06c49
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2

5.85e-051964842b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SULF1 LAMA2 CLSTN2 CA4

5.85e-05196484ee45e4de9d706ec87094e87f47d3e514539b8092
ToppCell10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

SULF1 LAMA2 CLSTN2 CA4

5.85e-05196484fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NHSL2 SULF1 LAMA2 ADGRG4

5.97e-051974840dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

QSOX1 KREMEN1 SULF1 CLSTN2

5.97e-051974841da8ba5bbab232add6e43ad78b15c2339d0c2bc3
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 CLSTN2

5.97e-05197484b349f8e96d61a4c296af64711e11fc44459a9413
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 SULF1 LAMA2

5.97e-0519748480e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PAMR1 LAMA2 CLSTN2 ADGRG4

5.97e-05197484c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MYOM1 OTOGL SULF1 STARD9

5.97e-05197484ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTSL1 PAMR1 LAMA2 CLSTN2

5.97e-05197484c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCellsevere-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CFP SPAG9 CD163 TNS3

6.08e-05198484a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCellbackground-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

QSOX1 ADAMTSL1 PAMR1 LAMA2

6.08e-0519848479f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCellbackground-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

QSOX1 ADAMTSL1 PAMR1 LAMA2

6.08e-05198484bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCellmetastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass

PAMR1 SULF1 LAMA2 CLSTN2

6.20e-0519948463eb2106bb6e2e33d020628583536c8d96662c84
ToppCellTracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NHSL2 SULF1 STARD9 LAMA2

6.33e-05200484b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

PAMR1 SULF1 LAMA2 CA4

6.33e-0520048464d2941689d7ca8af54f9ba21c5aeabf719084ef
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NHSL2 STARD9 LAMA2 ADGRG4

6.33e-052004843dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCellParenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PAMR1 SULF1 LAMA2 GREB1

6.33e-052004846b48ddde83bc6c941d557844aa214d4d2c8e736d
ToppCell10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

PAMR1 SULF1 LAMA2 CA4

6.33e-0520048476f3043cb88071256ff661885fe5a82a54f5b733
ToppCelldroplet-Marrow-nan-21m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

QSOX1 ADAMTSL1 PAMR1

2.86e-04119483aa3860c8d25c85baa79a0b6637bce2e269adfcc2
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

KLF11 CFP CD163

3.23e-04124483e9b6fdac2bef4bf1fee6a486f4628b68adc80f57
ToppCellCOVID-19_Mild-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients

DNAI4 SARAF CD163

3.30e-04125483e58c208b4355252ceabe04a468dd19a1f436182c
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MRNIP SARAF ADGRG4

3.79e-04131483a3a086ce6e69707ca6a042f3b15c130f81909acb
Drugaugustine

BLMH CFP GRIN1

3.15e-0614483CID000157561
Diseaselifestyle measurement, maximum cigarettes per day measurement

NRDE2 ADAMTSL1 LAMA2 CLSTN2

4.70e-05122484EFO_0009264, EFO_0010724
Diseaseautism spectrum disorder (implicated_via_orthology)

TMPRSS9 GRIN1 TBR1

1.96e-03152483DOID:0060041 (implicated_via_orthology)
Diseaseresponse to opioid

SARAF TEK

4.46e-0361482EFO_0008541

Protein segments in the cluster

PeptideGeneStartEntry
WKVPNGDCKTFQGPN

AAMP

201

Q13685
LGGWNSSGCKVKETN

ADGRG4

2696

Q8IZF6
VKPGQTCSVAGWGQT

GZMB

136

P10144
TVGACWQGGEVTKPQ

CLSTN2

496

Q9H4D0
CNKDWAIPGTNRGKA

C16orf46

171

Q6P387
GAVLAKKVNWIGCQG

QSOX1

381

O00391
QKGGETPGSEQWKFQ

SPAG9

221

O60271
GPQKGQAGLTWKVKQ

MRNIP

176

Q6NTE8
QAGLTWKVKQGSSPC

MRNIP

181

Q6NTE8
GNVGKTTWQNKESKG

LIMA1

646

Q9UHB6
NAQGTLTKGPLICWK

GREB1

196

Q4ZG55
QWQPCSRTCGGGVQK

ADAMTSL1

736

Q8N6G6
GINPKKQCISWEGTS

NRDE2

196

Q9H7Z3
RGTQNWTALQGGKPC

KREMEN1

41

Q96MU8
ESGQCWCQPGVTGKK

LAMA2

981

P24043
SGQGGSPCWKKQEQK

KMT2B

346

Q9UMN6
GWNGQCSGKVAPGTL

CFP

106

P27918
PTWLKTNGAVNGKGS

GBA

221

P04062
KWGGNCQKDRQSPIN

CA4

41

P22748
KNSIQWKGVGPGCNT

E2F4

76

Q16254
SIQWKGVGAGCNTKE

E2F5

111

Q15329
WGDGPQNATSLKCKS

C16orf96

976

A6NNT2
GKPITNQKSSGRCWI

BLMH

61

Q13867
GGQKKGWCTTPQLVA

DNAI4

26

Q5VTH9
KGQQAGWPGAVQTCS

KLF11

246

O14901
QGTGPIWLNEVKCKG

CD163

986

Q86VB7
DNWKCTGILKGNGSP

SEH1L

311

Q96EE3
VGPQWKNKLSGLCGN

OTOGL

1066

Q3ZCN5
KRTCQQNGEWSGKQP

PAMR1

326

Q6UXH9
QNGEWSGKQPICIKA

PAMR1

331

Q6UXH9
QNGGQWDGLKCQCPS

MUC3B

901

Q9H195
QRSVCTWGKNKPGIG

FAN1

506

Q9Y2M0
SSCSSWGNAPKKGLQ

TNRC6C

911

Q9HCJ0
FQGGKWVPCGKADTN

TBR1

266

Q16650
YTPKVIQCQNKGWDG

SARAF

76

Q96BY9
VNENGKNPSCGNSWV

NHSL2

411

Q5HYW2
KFSNWCGVQKGSPGG

STARD9

4141

Q9P2P6
GQLPFSKCAWGKAGV

TNS3

786

Q68CZ2
NWSRKAQQGKTGGCP

RHPN1

636

Q8TCX5
FQGGNTNWKPPLNCK

ZNF451

916

Q9Y4E5
KAPVGLKNVGNTCWF

USP25

166

Q9UHP3
VSWGIGCAQVKKPGV

TMPRSS9

706

Q7Z410
VNSGKFNPICKASGW

TEK

361

Q02763
QVGIISWGKSCGEKN

PRSS55

266

Q6UWB4
GVCNKYWKGTNQNGN

TRIM49D1

356

C9J1S8
GGWKAQVVKASGQNL

TGM1

191

P22735
QGVVSWGDGCAQKNK

PRSS1

211

P07477
QPGQKWQCIEDTSGK

SULF1

456

Q8IWU6
IVSWGDNCGQKDKPG

TMPRSS11A

386

Q6ZMR5
GQGGKLWDPSVQSCK

ZNF263

271

O14978
SVAGSGKWEPCNNNP

MYOM1

776

P52179
GKWEPCNNNPVKGSR

MYOM1

781

P52179
RGCVGNTNIWKTGPL

GRIN1

306

Q05586